EWTX - Edgewise Therapeutics GAAP EPS of -$0.32 beats by $0.02 August, 04 2022 09:13 AM Edgewise Therapeutics Inc. Edgewise Therapeutics press release ( NASDAQ: EWTX ): Q2 GAAP EPS of -$0.32 beats by $0.02 . Cash, cash equivalents and marketable securities of $248.4 million as of June 30, 2022 For further details see: Edgewise Therapeutics GAAP EPS of -$0.32 beats by $0.02